Stillcanna Strengthens Polish Team

Company Hires General Manager and Analyses Expert

VANCOUVER, BC / ACCESSWIRE / October 30, 2019 / StillCanna Inc.’s (CSE:STIL)(OTC:SCNNF)(FRA: 484) (“STIL” or the “Company”) is pleased to announce that it has hired two additional team members for the Company’s NEXUS extraction facility in Poland. Mr. Kazimierz Malik as General Manager and Mr. Piotr Bawiec, as Quality Assurance Manager.

Mr. Malik, now General Manager of the extraction facility, brings over 30 years of business administration experience, including the management of a network of medical clinics. Mr. Malik, a former professor at the University of Zielona Gora in Poland holds a Master’s Degree in philosophy and sociology. From daily logistical planning and oversight to production implementation and Standard Operating Procedures (SOP) s’, Mr. Malik will be responsible for the day-to-day operations of the NEXUS facility.

Mr. Piotr Bawiec has his pharmaceutical Masters Degree and is completing his doctorate in specific molecule analysis. He is a published researcher in Pharmacy and Medical Sciences dealing with specific trace molecules in various food products. Mr. Bawiec, the Quality Assurance Manager of the NEXUS facility will be focused on quality control and product testing throughout the extraction process.

“We continue to attract strong team members for Stillcanna and our Polish operations,” pointed out Jason Dussault CEO of Stillcanna. “You can’t expect to achieve great things without great people, I feel we just recruited yet another two. We welcome Piotr and Kazimierz to the Stillcanna family and we look forward to their contributions in meeting our milestones both today and in the future.”

About Stillcanna Inc.

StillCanna Inc.’s (CSE:STIL)(OTC:SCNNF)(FRA: 484) is a Canadian early-stage life sciences company focused on the large scale manufacturing of CBD in Europe. The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences LLC, a United Kingdom-based supplier of CBD. The Company also recently completed the acquisition of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is expected to increase the Company’s market share in the European CBD industry.

SOURCE: Stillcanna Inc.

Please See Disclaimer


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, StillCanna Inc. Market Jar Media Inc. has or expects to receive ninety two thousand eight hundred canadian dollars from StillCanna Inc.’s agency of record Native Ads Inc. for 30 campaign days (23 business days). In addition, Market Jar Media Inc. has or expects to receive four hundred and thirty six thousand in canadian dollars from StillCanna Inc.’s agency of record Native Ads Inc. for 60 campaign days (43 business days). Additionally, Market Jar Media Inc. has or expects to receive one hundred and fifty five thousand in canadian dollars from StillCanna Inc.’s agency of record Native Ads Inc. for 14 campaign days (10 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.